| Study Name |
Tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool |
| Study Acronym |
TAPS |
| Funding Agency |
NIDA NIH HHS,NIDA NIH HHS,NIDA NIH HHS,NIDA NIH HHS,NIDA NIH HHS,NIDA NIH HHS,NIMHD NIH HHS |
| Primary Research Focus |
We describe the design of the recently completed National Drug Abuse Treatment Clinical Trials Network's tobacco, alcohol, prescription medications, and substance use/misuse screen and brief assessment tool validation study. Study aims included to: develop a 2-stage screening and brief assessment tool (TAPS Tool) to detect substance use, problem use, and SUD among adult primary care patients; examine the validity of both the screen component and the TAPS Tool by comparing them to reference standard screening and assessment measures of no use, problem use, and SUD; and determine the feasibility and acceptability of the self-administration and interviewer-administration of the tool. |
| Study Design Name |
|
| Number Participants |
>1000 |
| Study Website |
https://www.drugabuse.gov/taps/#/ |
| Protocol Ids |
520102 |
| Grant Number |
UG1 DA013034,R33 DA027503,R01 DA019623,UG1 DA013035,U10 DA013727,UG1 DA040317,R01 MD007658 |
| Citation Link |
https://www.ncbi.nlm.nih.gov/pubmed/27444426 |